| Authors | Kevin L Winthrop, Amanda E Brunton, Susan Beekmann, Philip Polgreen, John Baddley, Kenneth G Saag, Cassandra Calabrese, Leonard Calabrese, Philip C Robinson, Zachary S Wallace, Jeffrey R Curtis, COVID-19 Study Team |
| Journal | Annals of the rheumatic diseases
(Ann Rheum Dis)
Vol. 80
Issue 2
Pg. 269-271
(02 2021)
ISSN: 1468-2060 [Electronic] England |
| PMID | 32759259
(Publication Type: Letter, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.)
|
| Chemical References |
- Anti-Bacterial Agents
- Antibodies, Monoclonal, Humanized
- Antirheumatic Agents
- Biological Products
- Enzyme Inhibitors
- Glucocorticoids
- Immunosuppressive Agents
- Janus Kinase Inhibitors
- Tumor Necrosis Factor Inhibitors
- Hydroxychloroquine
- Azithromycin
- tocilizumab
|
| Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Anti-Bacterial Agents
(therapeutic use)
- Antibodies, Monoclonal, Humanized
(therapeutic use)
- Antirheumatic Agents
(therapeutic use)
- Arthritis, Rheumatoid
(complications, drug therapy)
- Autoimmune Diseases
(complications, drug therapy)
- Azithromycin
(therapeutic use)
- Biological Products
(therapeutic use)
- COVID-19
(complications, mortality, therapy)
- Enzyme Inhibitors
(therapeutic use)
- Female
- Glucocorticoids
(therapeutic use)
- Hospitalization
- Humans
- Hydroxychloroquine
(therapeutic use)
- Immunomodulation
- Immunosuppressive Agents
(therapeutic use)
- Inflammatory Bowel Diseases
(complications, drug therapy)
- Intensive Care Units
- Janus Kinase Inhibitors
(therapeutic use)
- Male
- Middle Aged
- Respiration, Artificial
- SARS-CoV-2
- Sarcoidosis
(complications, drug therapy)
- Surveys and Questionnaires
- Tumor Necrosis Factor Inhibitors
(therapeutic use)
- Young Adult
- COVID-19 Drug Treatment
|
